![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Analysis of antiviral resistance to MK-7009
in protocol 004, a phase 1b monotherapy study
|
|
|
Reported by Jules Levin
4th Intl Workshop on Hep C Resistance and New Compounds
Boston, MA
June 2009
R.J.O Barnard, M. Feng, G. Ramos, A.L. Himmelberger, M.L. Miller, D.J. Graham, S.W Ludmerer, S.S Carroll, D.B. Olsen, E.K. Quirk, D.J.
Hazuda
![image002.gif](../images/120909/120909-1/image002.gif)
![image004.gif](../images/120909/120909-1/image004.gif)
![image006.gif](../images/120909/120909-1/image006.gif)
![image008.gif](../images/120909/120909-1/image008.gif)
![image010.gif](../images/120909/120909-1/image010.gif)
![image012.gif](../images/120909/120909-1/image012.gif)
![image014.gif](../images/120909/120909-1/image014.gif)
![image016.gif](../images/120909/120909-1/image016.gif)
![image018.gif](../images/120909/120909-1/image018.gif)
![image020.gif](../images/120909/120909-1/image020.gif)
![image022.gif](../images/120909/120909-1/image022.gif)
![image024.gif](../images/120909/120909-1/image024.gif)
![image026.gif](../images/120909/120909-1/image026.gif)
![image028.gif](../images/120909/120909-1/image028.gif)
![image030.gif](../images/120909/120909-1/image030.gif)
![image032.gif](../images/120909/120909-1/image032.gif)
![image034.gif](../images/120909/120909-1/image034.gif)
![image036.gif](../images/120909/120909-1/image036.gif)
![image038.gif](../images/120909/120909-1/image038.gif)
![image040.gif](../images/120909/120909-1/image040.gif)
![image042.gif](../images/120909/120909-1/image042.gif)
![image044.gif](../images/120909/120909-1/image044.gif)
![image046.gif](../images/120909/120909-1/image046.gif)
![image048.gif](../images/120909/120909-1/image048.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|